AERIS THERAPEUTICS INC has a total of 31 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, medical technology and macromolecular chemistry and polymers are CORMEDIX INC, IMARX THERAPEUTICS INC and POINT BIOMEDICAL CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Australia | 4 | |
#4 | Canada | 3 | |
#5 | China | 3 | |
#6 | EPO (European Patent Office) | 3 | |
#7 | Brazil | 2 | |
#8 | Israel | 2 | |
#9 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Macromolecular chemistry and polymers | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Object sterilising | |
#4 | Diagnosis and surgery | |
#5 | Syringes | |
#6 | Special macromolecular compounds | |
#7 | Compounding processes |
# | Name | Total Patents |
---|---|---|
#1 | Ingenito Edward P | 15 |
#2 | Tsai Larry W | 14 |
#3 | Schwarz Alexander | 13 |
#4 | Ingenito Ed | 6 |
#5 | Ingenito Edward | 5 |
#6 | Krom James A | 3 |
#7 | Edward Ingenito | 1 |
#8 | Ingenito Edward M D | 1 |
#9 | Alexander Schwarz | 1 |
Publication | Filing date | Title |
---|---|---|
WO2009055788A1 | Pneumoreductive therapy and compositions useful therein | |
CN101730714A | Lung volume reduction therapy using crosslinked non-natural polymers | |
WO2008124500A1 | Lung volume reduction therapy using crosslinked biopolymers | |
EP2059227A2 | Polymer systems for lung volume reduction therapy | |
US2008115787A1 | Respiratory assistance apparatus and method | |
BRPI0618216A2 | polycation-polyion complexes, compositions and methods of use thereof | |
AU2006200887A1 | Tissue volume reduction | |
US2005244401A1 | Compositions and methods for reducing lung volume | |
CA2530042A1 | Compositions and methods for reducing lung volume | |
EP1503766A2 | Compositions and methods for treating emphysema | |
US7654998B1 | Tissue volume reduction | |
AU6799300A | Tissue volume reduction |